Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> IntegrinBrian G. Feagan, Margaret K. Vandervoort, Gordon R. Greenberg et al.|New England Journal of Medicine|2005Cited by 694
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trialReena Khanna, Brian G. Feagan, Larry Stitt et al.|The Lancet|2015Cited by 462
The prevalence of primary sjögren's syndrome in a multiple sclerosis populationJohn H. Noseworthy, David A. Bell, B. Bass et al.|Annals of Neurology|1989Cited by 74
OP004 Early combined immunosuppression for the management of Crohn's disease: A community-based cluster randomized trialReena Khanna, Brian G. Feagan, Barrett G. Levesque et al.|Journal of Crohn s and Colitis|2014Cited by 19
1053 Early Combined Immunosuppression for the Management of Crohn's Disease: A Community-Based Cluster Randomized TrialReena Khanna, Brian G. Feagan, Barrett G. Levesque et al.|Gastroenterology|2014Cited by 10